Canada’s Genomics Enterprise (CGEn) is a national genome sequencing and analysis network with sites in Toronto, Montreal and Vancouver. Established in 2014, CGEn is funded primarily by the Canada Foundation for Innovation (CFI) and leverages investments from Genome Canada and other stakeholders.
To sustain Canada’s international leadership in genomics by providing breakthroughs in our knowledge of the molecular defects responsible for many important afflictions that strongly impact public health, and accelerate translation of these advances into improved health care and benefits to the community. CGEn will support hundreds of Canadian research scientists, across all disciplines of biology, in undertaking internationally competitive research based around genomics, bring new public and private sector partners forward, opening strategic opportunities and leveraging other investments.
CGEn’s mission is to enable Canadian science in basic and clinical research through the characterization of genome sequences, the promotion of this era of genome science research in Canada, and by building and operating an unprecedented infrastructure that enhances our national capacity for sequencing and informatics analysis.